Series B - SAB Biotherapeutics - Jul 17, 2020 Funding Round Profile - Cointime

比特币 ¥404,082.75 +1.78%
以太坊 ¥21,338.64 +2.03%
币安币 ¥3,596.95 +6.84%
Optimism ¥9.53 +4.12%
Arbitrum ¥4.43 +5.42%
Solana ¥963.23 +9.16%
Polygon ¥3.36 +6.10%
Cosmos ¥41.12 +9.03%
Avalanche ¥179.86 +12.30%

比特币 ¥404,082.75 +1.78%
以太坊 ¥21,338.64 +2.03%
币安币 ¥3,596.95 +6.84%
Optimism ¥9.53 +4.12%
Arbitrum ¥4.43 +5.42%
Solana ¥963.23 +9.16%
Polygon ¥3.36 +6.10%
Cosmos ¥41.12 +9.03%
Avalanche ¥179.86 +12.30%

SAB Biotherapeutics

company

Funding Round

Series B

Money Raised

$ 14M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Merck	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Sep 7, 2016	Grant	$ 1.42M	National Institutes of Health	Detail